NEW YORK (GenomeWeb News) — Bio-Rad Laboratories said today that it plans to offer $250 million in a private overseas debt offering to raise funds for working capital, and general corporate purposes, including acquisitions.

The company said that the $250 million aggregate senior subordinated notes will be offered only to qualified institutional buyers and may not be sold inside the United States.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.